I am a medical doctor with 16 years of experience in health systems strengthening, public policy, and implementation research. Currently, I serve as a Public Health Officer at the International Agency for Research on Cancer (IARC/WHO). In this role, I lead the design, implementation, and evaluation of equitable multi-cancer early detection research aimed at improving cancer outcomes globally, with a particular focus in low- and middle-income countries. I also provide technical assistance in developing and implementing policies and programmes for cancer prevention and early detection. Previously, I led national policy response for NCDs in Malaysia.

My name is Renata Chloupková, and I hold a Master's degree in Computational Biology from Masaryk University in Brno, Czech Republic (graduated in 2016). Currently, I work as a senior data analyst at the National Screening Center in the Czech Republic. As part of the team responsible for data analysis and management of screening programmes, I contribute to every stage of the process, from programme design and data collection to validation and evaluation. My role involves close collaboration with colleagues to ensure accurate and actionable insights, supporting the effectiveness of national health screening initiatives.

Urška Ivanuš is an MD with a postgraduate specialization and a PhD in public health focusing on cancer epidemiology and organised cancer screening. She is an assistant professor of management. She works at the Institute of Oncology Ljubljana as Director of the Slovenian Cervical Cancer Screening Programme and Registry ZORA. MoH appointed her to the Board of Experts of the National Cancer Control Plan and as the Head of the National Screening Committee, she was leading the development of a national framework for the implementation of new cancer screening programmes and is leading sustainability and leadership in Joint Action EUCANSCREEN.

Since July 2019, I have been employment at Steno Diabetes Center Aarhus, with the aim of launching a new research area concerning diabetes and cancer. It has turned out that my profile, as a pathologist with a PhD in clinical oncology and a special interest in epidemiological science has been a huge advance in this process. Type 2 diabetes is associated with a 20% higher risk of developing colorectal cancer, and I have investigated, whether people with type 2 diabetes have a different process and outcome of colorectal cabcer screening in terms of attendance, detection, treatment and prognosis.

Dr. Ethna McFerran, a Cancer Health Economist at Queen's University Belfast, has specialised in oncology health economics since beginning her nursing career in 2003. With a PhD in cancer health economics (2018), her work drives evidence-based decision-making and policy to improve cancer outcomes. She recently secured funding to model lung cancer screening health economics in Ireland/ Northern Ireland, focusing on health equity and early detection. A leader in cross-sector collaboration, Dr. McFerran has made significant contributions to cancer care policy, cost-effectiveness analysis, and digital health innovation, advocating for equitable healthcare and advancing health systems to support better cancer outcomes.

Brian Sheridan is a PhD student from Erasmus MC, Rotterdam. After several years working as a physiotherapist, he specialised in public health and completed an advanced Masters of Global Health in Belgium. His PhD project is focused on monitoring and evaluation of European cancer screening programmes.

Gaby Sroczynski is Associate Professor for Public Health, Health Data and Decision Science leading the Program on Decision Analysis at the Institute of Public Health, Medical Decision Making and HTA, UMIT TIROL–University for Health Sciences and Technology, Austria. She was a Research Scientist at the MGH Institute for Technology Assessment and Visiting Research Scholar at the Harvard Center for Risk Analysis, Harvard School of Public Health, Boston, USA. Her research interests include applying advanced methods in health data and decision science in the context of public health, health technology assessment and clinical guideline development with a focus on cancer prevention.

Specialist of radiotherapy and oncology, PhD, assistant professor - Head of the multidisciplinary board for thoracic malignancies at Institute of Oncology Ljubljana - Head of the lung cancer Expert group at the National Cancer Control Programme (NCCP) - Head of the research project: Framework development for evidence-based, sustainable implementation of organised population-based lung cancer screening in Slovenia (LUKA)